Summary
With the introduction of tandem mass spectrometry, newborn screening for disorders of propionate metabolism became widely available. However, there is controversy whether population screening for these disorders should be performed. The most widely used primary metabolite C3 itself has a poor specificity or lacks 100% sensitivity for milder forms and/or defects of cobalamin metabolism. Strategies to improve specificity have included the calculation of metabolite ratios (e.g. C3/C2) or second-tier strategies with analysis of methylmalonic acid or 2-methylcitric acid from the primary screening specimen. We report the results of a new statistical approach to identify parameter combinations that allow for 100% sensitivity as well as increased specificity. The promising results of this alternative approach will have to be substantiated on larger data sets.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bundesministerium für Gesundheit und Soziale Sicherung [1343 A] (2004) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Früherkennung von Krankheiten bei Kindern bis zur Vollendung des 6. Lebensjahres (Kinder-Richtlinien) zur Einführung des erweiterten Neugeborenen-Screenings Vom 21. Dezember 2004
Cavedon CA, Bourdoux P, Mertens K, et al (2005) Age related variations in acylcarnitine and free carnitine concentrations measured by tandem mass spectrometry. Clin Chem 51: 745–752. Medline doi:10.1373/clinchem.2004.043646
Chace DH, DiPerna JC, Kalas RA, Johnson RW, Naylor Rapid EW (2001) Diagnosis of Methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem, 47: 2040–2044. Medline
Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49: 1797–1817. Medline. doi:10.1373/clinchem.2003.022178
DGNS (2004) Screeningreport 2004 Retríeved from http://www.screening-dgns.de/PDF/Screeningreport_2004.pdf#page = 6 31st Jan 2007. Accessed 05/05/2008.
Dionisi-Vici C, Deodato F, Röschinger W, Rhead W, Wilcken B (2006) Classical organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29: 383–389. Medline. doi:10.1007/s10545-006-0278-z
Fayyad UM, Irani KB (1992) On the handling of continuous-valued attributes in decision tree generation. Machine Learning 8: 87–102.
Hewlett J, Waisbren SE (2006) Review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis 29: 677–682. Medline. doi:10.1007/s10545-006-0381-1
Hu YJ, Kibler D (1996) Generation of attributes for learning algorithms. In: Proceeding of the 13th National Conference on Artificial Intelligence, 1996; 806–811.
La Marca G, Malvagia S, Paquini E, Innocenti M, Donati MA, Zammarchi E (2007) Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandemmass spectrometry. Clin Chem 53: 1364–1369.
Leonard JV, Vijayaraghavan S, Walter JH (2003) The impact of screening for propionic and methylmalonic acidaemia. Eur J Pediatr 162: S21–S24.
Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P (2007) Reduction of the false-positive rate in newborn screening by implementation of MS/MS based second-tier tests: the Mayo clinic experience (2004–2007). J Inherit Metab Dis 30: 585–592.
Meyburg J, Schulze A, Kohlmueller D, Pöschl J, et al (2002) Acylcarnitine profiles of preterm infants over the first weeks of life. Pediatr Res 52: 720–723.
Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome and implications. Pediatrics 111: 1399–1406.
Sniderman LC, Lambert M, Giguere R, et al (1999) Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening programme. J Pediatr 134: 675–682.
Walter J (2003) Arguments for early screening: a clinician’s perspective. Eur J Paediatr 162: S2–S4.
Watson MS, et al. American College of Medical Genetics Newborn Screening Expert Group (2006). Newborn screening: toward a uniform panel and system – executive summary. Pediatrics 117: S296–S307.
Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2304–2312.
Witten IH, Frank E (2005) Data Mining: Practical Machine Learning Tools and Techniques, 2nd edn. San Francisco: Morgan Kaufmann.
Zytkovicz TH, Fitzgerald EF, Marsden D, et al (2001) Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 47: 1945–1955.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Rodney Pollitt
Competing interests: None declared
References to electronic databases: Propionic aciduria: OMIM #606054. Methylmalonyl-CoA mutase deficiency: OMIM #251000. Cobalamin disorders: CblA, OMIM #251100; CblB:, OMIM #251110; CblC/D, OMIM #277400/%277410; CblF, OMIM %277380.
Rights and permissions
About this article
Cite this article
Lindner, M., Ho, S., Kölker, S. et al. Newborn screening for methylmalonic acidurias—Optimization by statistical parameter combination. J Inherit Metab Dis 31, 379–385 (2008). https://doi.org/10.1007/s10545-008-0892-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0892-z